Schistosome infection promotes osteoclastmediated bone loss

11Citations
Citations of this article
16Readers
Mendeley users who have this article in their library.

Abstract

Infection with schistosome results in immunological changes that might influence the skeletal system by inducing immunological states affecting bone metabolism. We investigated the relationships between chronic schistosome infection and bone metabolism by using a mouse model of chronic schistosomiasis, affecting millions of humans worldwide. Results showed that schistosome infection resulted in aberrant osteoclast-mediated bone loss, which was accompanied with an increased level of receptor activator of nuclear factor-κB (NF-κB) Ligand (RANKL) and decreased level of osteoprotegerin (OPG). The blockade of RANKL by the anti-RANKL antibody could prevent bone loss in the context of schistosome infection. Meanwhile, both B cells and CD4+ T cells, particularly follicular helper T (Tfh) cell subset, were the important cellular sources of RANKL during schistosome infection. These results highlight the risk of bone loss in schistosome-infected patients and the potential benefit of coupling bone therapy with anti-schistosome treatment.

Cite

CITATION STYLE

APA

Li, W., Wei, C., Xu, L., Yu, B., Chen, Y., Lu, D., … Sui, C. (2021). Schistosome infection promotes osteoclastmediated bone loss. PLoS Pathogens, 17(3). https://doi.org/10.1371/journal.ppat.1009462

Register to see more suggestions

Mendeley helps you to discover research relevant for your work.

Already have an account?

Save time finding and organizing research with Mendeley

Sign up for free